IL1B and liver cancer: Our KEGG enrichment analysis results implied that another possible function of FGF9 in liver cancer is the activation of inflammation, a feature also associated with NASH.[51] This possibility is further supported by the expression of inflammatory factors, such as TNF‐α, IL‐6 and IL‐1β, in the livers of FGF9 TG mice.